328 related articles for article (PubMed ID: 28864169)
61. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species.
Chen M; Zhai L; Arendrup MC
Med Mycol; 2015 Feb; 53(2):194-8. PubMed ID: 25605775
[TBL] [Abstract][Full Text] [Related]
62. Green tea extract and its major constituent, epigallocatechin-3-gallate, induce epithelial beta-defensin secretion and prevent beta-defensin degradation by Porphyromonas gingivalis.
Lombardo Bedran TB; Feghali K; Zhao L; Palomari Spolidorio DM; Grenier D
J Periodontal Res; 2014 Oct; 49(5):615-23. PubMed ID: 24206194
[TBL] [Abstract][Full Text] [Related]
63. Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Bauer J; Verhoff M; Hoffmann M; Northoff H; Werz O
Biochem Biophys Res Commun; 2009 Oct; 388(2):350-4. PubMed ID: 19665000
[TBL] [Abstract][Full Text] [Related]
64. Epigallocatechin Gallate Attenuates β-Amyloid Generation and Oxidative Stress Involvement of PPARγ in N2a/APP695 Cells.
Zhang ZX; Li YB; Zhao RP
Neurochem Res; 2017 Feb; 42(2):468-480. PubMed ID: 27889855
[TBL] [Abstract][Full Text] [Related]
65. Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells.
Kim SJ; Jeong HJ; Lee KM; Myung NY; An NH; Yang WM; Park SK; Lee HJ; Hong SH; Kim HM; Um JY
J Nutr Biochem; 2007 Sep; 18(9):587-96. PubMed ID: 17446059
[TBL] [Abstract][Full Text] [Related]
66. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent activation of extracellular signal-regulated kinase 1/2 in Jurkat cells.
Song S; Huang YW; Tian Y; Wang XJ; Sheng J
Chin J Nat Med; 2014 Sep; 12(9):654-62. PubMed ID: 25263976
[TBL] [Abstract][Full Text] [Related]
67. In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
Weisburg JH; Weissman DB; Sedaghat T; Babich H
Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):191-200. PubMed ID: 15504155
[TBL] [Abstract][Full Text] [Related]
68. Tea Plant (
Brimson JM; Prasanth MI; Kumaree KK; Thitilertdecha P; Malar DS; Tencomnao T; Prasansuklab A
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615695
[TBL] [Abstract][Full Text] [Related]
69. Autoxidation-Resistant, ROS-Scavenging, and Anti-Inflammatory Micellar Nanoparticles Self-Assembled from Poly(acrylic acid)-Green Tea Catechin Conjugates.
Bae KH; Chan KH; Kurisawa M
ACS Macro Lett; 2022 Jul; 11(7):835-840. PubMed ID: 35713474
[TBL] [Abstract][Full Text] [Related]
70. The Pharmacological Activity of
Sánchez M; González-Burgos E; Iglesias I; Lozano R; Gómez-Serranillos MP
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294991
[TBL] [Abstract][Full Text] [Related]
71. Positive effects of the tea catechin (-)-epigallocatechin-3-gallate on gut bacteria and fitness of Ectropis obliqua Prout (Lepidoptera: Geometridae).
Zhang Y; Zhao T; Deng J; Zhou X; Wu Z; Su Q; Zhang L; Long Y; Yang Y
Sci Rep; 2019 Mar; 9(1):5021. PubMed ID: 30903009
[TBL] [Abstract][Full Text] [Related]
72. Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.
Kanlaya R; Thongboonkerd V
Adv Nutr; 2019 Jan; 10(1):112-121. PubMed ID: 30615092
[TBL] [Abstract][Full Text] [Related]
73. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis.
Riegsecker S; Wiczynski D; Kaplan MJ; Ahmed S
Life Sci; 2013 Sep; 93(8):307-12. PubMed ID: 23871988
[TBL] [Abstract][Full Text] [Related]
74. Development and Optimization of Epigallocatechin-3-Gallate (EGCG) Nano Phytosome Using Design of Experiment (DoE) and Their In Vivo Anti-Inflammatory Studies.
H Shariare M; Afnan K; Iqbal F; A Altamimi M; Ahamad SR; S Aldughaim M; K Alanazi F; Kazi M
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233756
[TBL] [Abstract][Full Text] [Related]
75. Prooxidant Effects of Epigallocatechin-3-Gallate in Health Benefits and Potential Adverse Effect.
Ouyang J; Zhu K; Liu Z; Huang J
Oxid Med Cell Longev; 2020; 2020():9723686. PubMed ID: 32850004
[TBL] [Abstract][Full Text] [Related]
76. Chemico-biological aspects of
Sahadevan R; Singh S; Binoy A; Sadhukhan S
Crit Rev Food Sci Nutr; 2023; 63(30):10382-10411. PubMed ID: 35491671
[TBL] [Abstract][Full Text] [Related]
77. Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate.
Zhang S; Mao B; Cui S; Zhang Q; Zhao J; Tang X; Chen W
Crit Rev Food Sci Nutr; 2024; 64(19):6546-6566. PubMed ID: 36728926
[TBL] [Abstract][Full Text] [Related]
78. Effects of epigallocatechin-3-gallate of
Bazyar H; Hosseini SA; Saradar S; Mombaini D; Allivand M; Labibzadeh M; Alipour M
J Complement Integr Med; 2020 Dec; 18(2):405-411. PubMed ID: 34187117
[TBL] [Abstract][Full Text] [Related]
79. Biological Effects of EGCG@MOF Zn(BTC)
Li S; Yan J; Zhu Q; Liu X; Li S; Wang S; Wang X; Sheng J
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080195
[TBL] [Abstract][Full Text] [Related]
80. Multi-target Approaches of Epigallocatechin-3-O-gallate (EGCG) and its Derivatives against Influenza Viruses.
da Silva-Júnior EF; Silva LR
Curr Top Med Chem; 2022; 22(18):1485-1500. PubMed ID: 35086449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
